US Stock MarketDetailed Quotes

INCY Incyte

Watchlist
  • 75.870
  • -1.860-2.39%
Close Nov 15 16:00 ET
  • 75.870
  • 0.0000.00%
Post 20:01 ET
14.62BMarket Cap843.00P/E (TTM)

Incyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
110.28%310.87M
-287.77%-575.56M
307.20%218.81M
-48.81%496.49M
-47.92%147.73M
-50.12%147.84M
76.01%306.53M
-148.95%-105.6M
29.41%969.94M
145.91%283.66M
Net income from continuing operations
-37.84%106.46M
-318.43%-444.6M
681.22%169.55M
75.42%597.6M
606.51%201.08M
51.87%171.27M
26.09%203.55M
-42.87%21.7M
-64.09%340.66M
-94.95%28.46M
Operating gains losses
-51.29%12.98M
----
----
----
----
--26.65M
----
----
----
----
Depreciation and amortization
5.28%22.52M
8.63%22.05M
14.24%21.95M
21.82%82.66M
19.45%21.76M
28.15%21.39M
22.96%20.3M
16.87%19.21M
17.31%67.86M
22.61%18.22M
Deferred tax
-9.08%-33.88M
55.97%-17.48M
-54.54%-34.25M
-378.32%-158.9M
-496.06%-65.98M
-490.29%-31.06M
-230.73%-39.7M
-1,152.37%-22.16M
112.26%57.09M
103.58%16.66M
Other non cash items
492.30%16M
-92.83%527K
-29.53%2.5M
75.44%51.78M
43.45%38.18M
117.70%2.7M
-24.09%7.36M
-58.16%3.55M
82.66%29.52M
1,322.04%26.62M
Change In working capital
219.47%108.87M
-249.98%-153.45M
153.18%99.24M
-225.07%-248.65M
-158.33%-73.25M
-171.10%-91.12M
188.79%102.32M
-409.42%-186.6M
1,464.61%198.81M
416.69%125.58M
-Change in receivables
-0.68%-19.4M
145.59%6.48M
-109.34%-1.97M
-245.28%-98.68M
-223.31%-86.29M
-129.75%-19.27M
88.22%-14.21M
-60.91%21.09M
78.72%-28.58M
73.20%-26.69M
-Change in inventory
64.74%-8.38M
-38.09%-27.78M
-71.66%-57.2M
-152.06%-170.15M
-384.46%-92.96M
-113.53%-23.76M
13.62%-20.12M
-139.66%-33.32M
-221.98%-67.5M
-303.96%-19.19M
-Change in prepaid assets
70.98%-15.63M
-335.82%-38.05M
93.03%-1.7M
-38.23%-42.49M
111.17%19.59M
-268.01%-53.86M
241.42%16.14M
-74.32%-24.35M
52.03%-30.74M
123.61%9.28M
-Change in payables and accrued expense
2,541.88%152.28M
-178.09%-94.1M
206.73%160.1M
-80.75%62.67M
-46.72%86.41M
-93.53%5.76M
200.61%120.51M
-538.33%-150.01M
59.01%325.63M
55.94%162.18M
Cash from discontinued investing activities
Operating cash flow
110.28%310.87M
-287.77%-575.56M
307.20%218.81M
-48.81%496.49M
-47.92%147.73M
-50.12%147.84M
76.01%306.53M
-148.95%-105.6M
29.41%969.94M
145.91%283.66M
Investing cash flow
Cash flow from continuing investing activities
322.67%38.27M
2,978.18%213.82M
-156.00%-73.11M
-164.42%-207.68M
-638.81%-154.5M
39.48%-17.19M
40.47%-7.43M
-70.52%-28.56M
62.18%-78.54M
68.34%-20.91M
Capital expenditure reported
52.74%-5.19M
-637.94%-54.14M
19.80%-9.55M
58.26%-32.49M
89.34%-2.27M
60.53%-10.98M
37.52%-7.34M
29.99%-11.91M
57.00%-77.83M
38.27%-21.27M
Net intangibles purchase and sale
---12.5M
---1.4M
--0
---15M
--0
--0
--0
---15M
--0
--0
Net investment purchase and sale
1,000.71%55.96M
292,885.87%269.36M
-3,745.31%-63.56M
-22,493.94%-160.19M
-42,269.81%-152.23M
-951.27%-6.21M
87.52%-92K
-740.70%-1.65M
97.34%-709K
101.14%361K
Cash from discontinued investing activities
Investing cash flow
322.67%38.27M
2,978.18%213.82M
-156.00%-73.11M
-164.42%-207.68M
-638.81%-154.5M
39.48%-17.19M
40.47%-7.43M
-70.52%-28.56M
62.18%-78.54M
68.34%-20.91M
Financing cash flow
Cash flow from continuing financing activities
13.17%-32.35M
-15,620.49%-2B
-409.63%-12.41M
-2,423.05%-20.03M
113.95%346K
-160.33%-37.26M
-19.07%12.87M
4,076.04%4.01M
-112.86%-794K
-127.54%-2.48M
Net issuance payments of debt
-10.62%-979K
-8.97%-911K
-8.60%-871K
-17.40%-3.36M
-10.71%-837K
-19.92%-885K
-19.43%-836K
-20.06%-802K
-18.41%-2.86M
-20.19%-756K
Net common stock issuance
---103K
-14,234.89%-2.01B
-96.59%477K
----
----
--0
---13.99M
--13.99M
----
----
Proceeds from stock option exercised by employees
2,770.83%1.28M
----
----
-41.36%35.84M
-58.53%7.52M
-100.91%-48K
----
----
4.25%61.12M
77.81%18.13M
Net other financing activities
10.38%-32.55M
-798.07%-6.06M
-30.97%-12.02M
11.07%-52.51M
68.09%-6.33M
-92.49%-36.32M
85.62%-675K
41.30%-9.18M
-18.02%-59.05M
-3,444.64%-19.85M
Cash from discontinued financing activities
Financing cash flow
13.17%-32.35M
-15,620.49%-2B
-409.63%-12.41M
-2,423.05%-20.03M
113.95%346K
-160.33%-37.26M
-19.07%12.87M
4,076.04%4.01M
-112.86%-794K
-127.54%-2.48M
Net cash flow
Beginning cash position
-68.43%988.92M
18.60%3.35B
8.88%3.22B
43.41%2.95B
19.94%3.23B
28.55%3.13B
24.99%2.82B
43.41%2.95B
35.94%2.06B
34.56%2.69B
Current changes in cash
239.22%316.79M
-856.15%-2.36B
202.41%133.29M
-69.82%268.78M
-102.47%-6.43M
-63.18%93.39M
75.68%311.97M
-165.37%-130.15M
62.53%890.61M
346.36%260.27M
Effect of exchange rate changes
-95.29%128K
100.69%13K
-239.70%-676K
-298.99%-6.68M
-1,264.43%-7.3M
77.45%2.72M
-291.40%-1.89M
-194.76%-199K
193.98%3.36M
323.65%627K
End cash Position
-59.56%1.31B
-68.43%988.92M
18.60%3.35B
8.88%3.22B
8.88%3.22B
19.94%3.23B
28.55%3.13B
24.99%2.82B
43.41%2.95B
43.41%2.95B
Free cash flow
114.22%293.18M
-310.94%-631.11M
257.92%209.26M
-49.67%449M
-44.56%145.46M
-49.04%136.86M
84.21%299.19M
-166.68%-132.51M
56.93%892.11M
224.39%262.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 110.28%310.87M-287.77%-575.56M307.20%218.81M-48.81%496.49M-47.92%147.73M-50.12%147.84M76.01%306.53M-148.95%-105.6M29.41%969.94M145.91%283.66M
Net income from continuing operations -37.84%106.46M-318.43%-444.6M681.22%169.55M75.42%597.6M606.51%201.08M51.87%171.27M26.09%203.55M-42.87%21.7M-64.09%340.66M-94.95%28.46M
Operating gains losses -51.29%12.98M------------------26.65M----------------
Depreciation and amortization 5.28%22.52M8.63%22.05M14.24%21.95M21.82%82.66M19.45%21.76M28.15%21.39M22.96%20.3M16.87%19.21M17.31%67.86M22.61%18.22M
Deferred tax -9.08%-33.88M55.97%-17.48M-54.54%-34.25M-378.32%-158.9M-496.06%-65.98M-490.29%-31.06M-230.73%-39.7M-1,152.37%-22.16M112.26%57.09M103.58%16.66M
Other non cash items 492.30%16M-92.83%527K-29.53%2.5M75.44%51.78M43.45%38.18M117.70%2.7M-24.09%7.36M-58.16%3.55M82.66%29.52M1,322.04%26.62M
Change In working capital 219.47%108.87M-249.98%-153.45M153.18%99.24M-225.07%-248.65M-158.33%-73.25M-171.10%-91.12M188.79%102.32M-409.42%-186.6M1,464.61%198.81M416.69%125.58M
-Change in receivables -0.68%-19.4M145.59%6.48M-109.34%-1.97M-245.28%-98.68M-223.31%-86.29M-129.75%-19.27M88.22%-14.21M-60.91%21.09M78.72%-28.58M73.20%-26.69M
-Change in inventory 64.74%-8.38M-38.09%-27.78M-71.66%-57.2M-152.06%-170.15M-384.46%-92.96M-113.53%-23.76M13.62%-20.12M-139.66%-33.32M-221.98%-67.5M-303.96%-19.19M
-Change in prepaid assets 70.98%-15.63M-335.82%-38.05M93.03%-1.7M-38.23%-42.49M111.17%19.59M-268.01%-53.86M241.42%16.14M-74.32%-24.35M52.03%-30.74M123.61%9.28M
-Change in payables and accrued expense 2,541.88%152.28M-178.09%-94.1M206.73%160.1M-80.75%62.67M-46.72%86.41M-93.53%5.76M200.61%120.51M-538.33%-150.01M59.01%325.63M55.94%162.18M
Cash from discontinued investing activities
Operating cash flow 110.28%310.87M-287.77%-575.56M307.20%218.81M-48.81%496.49M-47.92%147.73M-50.12%147.84M76.01%306.53M-148.95%-105.6M29.41%969.94M145.91%283.66M
Investing cash flow
Cash flow from continuing investing activities 322.67%38.27M2,978.18%213.82M-156.00%-73.11M-164.42%-207.68M-638.81%-154.5M39.48%-17.19M40.47%-7.43M-70.52%-28.56M62.18%-78.54M68.34%-20.91M
Capital expenditure reported 52.74%-5.19M-637.94%-54.14M19.80%-9.55M58.26%-32.49M89.34%-2.27M60.53%-10.98M37.52%-7.34M29.99%-11.91M57.00%-77.83M38.27%-21.27M
Net intangibles purchase and sale ---12.5M---1.4M--0---15M--0--0--0---15M--0--0
Net investment purchase and sale 1,000.71%55.96M292,885.87%269.36M-3,745.31%-63.56M-22,493.94%-160.19M-42,269.81%-152.23M-951.27%-6.21M87.52%-92K-740.70%-1.65M97.34%-709K101.14%361K
Cash from discontinued investing activities
Investing cash flow 322.67%38.27M2,978.18%213.82M-156.00%-73.11M-164.42%-207.68M-638.81%-154.5M39.48%-17.19M40.47%-7.43M-70.52%-28.56M62.18%-78.54M68.34%-20.91M
Financing cash flow
Cash flow from continuing financing activities 13.17%-32.35M-15,620.49%-2B-409.63%-12.41M-2,423.05%-20.03M113.95%346K-160.33%-37.26M-19.07%12.87M4,076.04%4.01M-112.86%-794K-127.54%-2.48M
Net issuance payments of debt -10.62%-979K-8.97%-911K-8.60%-871K-17.40%-3.36M-10.71%-837K-19.92%-885K-19.43%-836K-20.06%-802K-18.41%-2.86M-20.19%-756K
Net common stock issuance ---103K-14,234.89%-2.01B-96.59%477K----------0---13.99M--13.99M--------
Proceeds from stock option exercised by employees 2,770.83%1.28M---------41.36%35.84M-58.53%7.52M-100.91%-48K--------4.25%61.12M77.81%18.13M
Net other financing activities 10.38%-32.55M-798.07%-6.06M-30.97%-12.02M11.07%-52.51M68.09%-6.33M-92.49%-36.32M85.62%-675K41.30%-9.18M-18.02%-59.05M-3,444.64%-19.85M
Cash from discontinued financing activities
Financing cash flow 13.17%-32.35M-15,620.49%-2B-409.63%-12.41M-2,423.05%-20.03M113.95%346K-160.33%-37.26M-19.07%12.87M4,076.04%4.01M-112.86%-794K-127.54%-2.48M
Net cash flow
Beginning cash position -68.43%988.92M18.60%3.35B8.88%3.22B43.41%2.95B19.94%3.23B28.55%3.13B24.99%2.82B43.41%2.95B35.94%2.06B34.56%2.69B
Current changes in cash 239.22%316.79M-856.15%-2.36B202.41%133.29M-69.82%268.78M-102.47%-6.43M-63.18%93.39M75.68%311.97M-165.37%-130.15M62.53%890.61M346.36%260.27M
Effect of exchange rate changes -95.29%128K100.69%13K-239.70%-676K-298.99%-6.68M-1,264.43%-7.3M77.45%2.72M-291.40%-1.89M-194.76%-199K193.98%3.36M323.65%627K
End cash Position -59.56%1.31B-68.43%988.92M18.60%3.35B8.88%3.22B8.88%3.22B19.94%3.23B28.55%3.13B24.99%2.82B43.41%2.95B43.41%2.95B
Free cash flow 114.22%293.18M-310.94%-631.11M257.92%209.26M-49.67%449M-44.56%145.46M-49.04%136.86M84.21%299.19M-166.68%-132.51M56.93%892.11M224.39%262.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept CAR-T Therapy
CAR-T Therapy
Intraday-1.43%